Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advocating with You

Laurie Hughell, PA-C, MPH  |  Issue: June 2011  |  June 13, 2011

Laurie Hughell, PA-C, MPH

In the field of rheumatology, we see the direct impact that healthcare policy has on our patients in regard to insurance and drug coverage, prior authorizations, reimbursement, and the importance of research in the discovery of new therapies. Although our goal is to continue to provide high-quality care to the patients we treat, we also know the challenges–and barriers–that healthcare providers face when trying to do so.

Prior to joining the Government Affairs Committee as an ARHP representative, I had little knowledge of or experience in the workings of the U.S. political system. Now, my knowledge base has increased significantly, and I have found it quite fulfilling to be part of the legislative process. I am very grateful for the opportunity to attend Advocates for Arthritis, the ACR’s annual Capitol Hill Fly-In, so that I can advocate for the patients that I work with on a daily basis. Though I am not a seasoned veteran, having been to The Hill with the ACR three times, there are three things that I have come to realize:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Now Accepting Applications for Advocates for Arthritis

Apply today to attend Advocates for Arthritis September 19–20 in Washington, D.C. Don’t miss this opportunity to educate Congress on the impact arthritis and rheumatic diseases have on one’s quality of life and the importance of care provided by a rheumatology professional. The ACR also is looking for patient advocates, so encourage your patients to apply as well. For applications and more information, go to www.rheumatology.org/advocacy.

  1. You do not have to be an expert on politics or health care policy to attend Advocates for Arthritis. The ACR does an excellent job in educating attendees on the issues relevant to the rheumatology community. Building your knowledge base on these subjects also helps you understand what is happening in the healthcare arena.
  2. Your comfort level will increase every time you attend. I’ll admit that the first time I went to Capitol Hill was anxiety provoking, but it does get easier over time. It is also enjoyable to build a relationship with your members of Congress and their staff.
  3. It is exciting to be part of the political process. By lobbying for important arthritis legislation, we are able to make an impact on the future of our patients and our profession. That became evident for me after attending Advocates for Arthritis in September 2010. At that time, one of our main issues was to ask our senators and representatives to sign on to a bill to support access to preventative osteoporosis testing. After meeting with one of the Iowa representatives, I received a personal phone call from his legislative aide on health to inform us that the representative had decided to sign on to the bill in support. The aide informed me that our personal visit and the information we shared was the reason that the congressman decided to support this legislation. It was invigorating to find out that we do have influence and we can affect change.

Given today’s political climate surrounding healthcare policy, the voice of the ACR—our collective voices—needs to be heard. Lobbying at Advocates for Arthritis is an integral part of how you can become involved in making a difference for rheumatology. I encourage all ACR and ARHP members, especially those who have never attended, to apply for Advocates for Arthritis. It is an eye-opening experience.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 | Single Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:AC&RAdvocacyAdvocates for ArthritisCongressLegislationPoliticsrheumatology

Related Articles

    The 2018 ARHP Merit Awards & ACR Distinguished Fellows

    December 18, 2018

    CHICAGO—At the 2018 ACR/ARHP Annual Meeting in October, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARHP Merit Awards about their individual contributions to advancing rheumatology. You’ll also find interviews…

    The ACR/ARHP Award Winners Discuss Their Contributions to Rheumatology

    January 19, 2016

    At the 2015 ACR/ARHP Annual Meeting in San Francisco in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. In the December 2015 issue, The Rheumatologist reported on the ACR’s awards. This month, we speak with the ARHP winners about…

    Advocating for Arthritis: My First Time on the Hill

    July 1, 2010

    Amidst the most momentous week of the year’s tumultuous healthcare reform activities, we arrived in Washington, D.C., for the annual ACR Advocates for Arthritis Capitol Hill Fly-In. This was to be my first visit to Congress. Although my alma mater, Georgetown University, was a short distance from the Capitol dome, as a student I had little interest in the political process—particularly as it related to medicine. Now, however, as a young rheumatologist, I am increasingly aware of the impact health policy has on my daily practice. I have also watched the healthcare reform debate unfold over the last year, recognizing that this is a critical time for physicians to be vocal and active. There is a great deal at stake, and we are surrounded daily by the very issues debated in Washington. Why not take our opinions directly to the decision makers?

    Fellows’ Forum: Why Rheumatology Fellows Should Get Involved with Advocacy

    May 16, 2017

    Introduction Interest in rheumatology continues to grow, with more than 240 new adult and pediatric fellows to begin their training in the coming academic year. Given the broad and diverse career opportunities, it is an ACR goal to help guide trainees in their career decisions and professional development. Rheumatology fellowship often marks the transition from…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences